GlassScriptPhysician profile
Andrew David Smith
NPI 1174793806
$5,432.84
in general payments reported to CMS, 2019-2025
41 companies · $801 in 2025
The $801 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $508 · 2021: $530 · 2022: $522 · 2023: $845 · 2024: $1,392 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811 · Travel and Lodging: $192 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.25 |
| Travel and Lodging | $191.66 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,270.00 | 2019-2025 | Botox, Lupron Depot |
| Bluewind Medical | $544.71 | 2024-2025 | Revi |
| Allergan, INC. | $419.27 | 2019-2022 | |
| Astellas Pharma US INC | $390.62 | 2020-2024 | Myrbetriq |
| Glaxosmithkline, LLC. | $374.41 | 2019-2024 | Trelegy Ellipta |
| 180 Medical, INC. | $351.45 | 2019-2025 | Cure Catheter, Cure Ultra Catheter, Gentlecath Glide |
| Boston Scientific Corporation | $277.10 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Solyx Sis System |
| Blue Earth Diagnostics | $205.75 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $183.80 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $145.57 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.07 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $125.73 | 2019-2023 | Aveed, Xiaflex |
| Femselect INC. | $106.80 | 2023 | Enplace |
| Vertex Pharmaceuticals Incorporated | $62.48 | 2024-2025 | |
| Karl Storz Endoscopy-America | $59.77 | 2020-2024 | N.A. |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $58.30 | 2019-2023 | Itind System |
| Laborie Medical Technologies Corp. | $57.09 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Eclipse |
| Ferring Pharmaceuticals INC. | $53.53 | 2024-2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $52.15 | 2019 | |
| Accord Healthcare, INC. | $47.08 | 2023-2024 | |
| Pfizer INC. | $42.19 | 2020-2021 | |
| Profound Medical Corp. | $40.46 | 2025 | Tulsa-Pro |
| Baxter Healthcare | $38.22 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Tolmar, INC. | $34.39 | 2025 | Eligard, Jatenzo |
| Dendreon Pharmaceuticals LLC | $33.30 | 2019 | |
| La Jolla Pharmaceutical Company | $31.33 | 2023 | Giapreza |
| Janssen Biotech, INC. | $25.01 | 2019 | |
| Coloplast Corp | $23.35 | 2023 | Saffron |
| Urogen Pharma, INC. | $22.60 | 2025 | |
| Tempus Ai, INC | $22.48 | 2025 | Xt Cdx |
| Dentsply Ih INC. | $19.95 | 2019 | |
| Palette Life Sciences, INC. | $19.85 | 2023 | |
| Rochester Medical Corporation | $19.51 | 2019 | |
| Abc Home Medical Supply, INC. | $17.34 | 2025 | |
| Ambu INC. | $16.04 | 2025 | |
| Therapeuticsmd, INC. | $14.64 | 2019 | |
| Abbott Laboratories | $14.63 | 2024 | Infinity |
| Photocure INC | $14.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.64 | 2020 | |
| Advanced Respiratory, INC | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.